InvestorsHub Logo

KMBJN

08/15/18 5:39 PM

#13286 RE: Jkings #13285

Raising $20M at ?? $.75? for >50% dilution? Guess we'll find out soon.

Brief prospectus skim made interesting reading. I like the strategy of 4 targeted sectors / areas, using 10 sales and support staff.

Good to go after correctional facilities, addiction facilities, and large prescribers.

Interesting that sublocade (Indivior's buprenorphine depot) also not selling very well:

https://seekingalpha.com/article/4190227-indivior-plc-adr-invvy-ceo-shaun-thaxter-q2-2018-results-earnings-call-transcript?part=single

$2M first half revenue, but still expecting $1B+ sales potential.

Hopefully Probuphine can pick up, and it's good that we now own 100% of revenue.

This money should last at least through end of 2019 I believe they said. Should be enough time to turn things around.

Europe should be up and running by then.